Latest News and Press Releases
Want to stay updated on the latest news?
-
Abides forskningsplatform i verdensklasse fokuserer på udnyttelsen af det terapeutiske potentiale i en af de største og mest alsidige enzymklasser - serinhydrolaserne (SH'er) - med potentiale til at...
-
Valby, Denmark, 26 March 2019 - H. Lundbeck A/S (Lundbeck) announced today that the report by the Board of Directors was adopted and the annual report was approved at the annual general meeting. The...
-
Valby, Danmark, 26. marts 2019 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, at bestyrelsens beretning blev taget til efterretning og årsrapporten blev godkendt på generalforsamlingen. ...
-
Valby, Denmark, 8 March 2019 - H. Lundbeck A/S (Lundbeck) today announced the appointment of Keld Flintholm Jørgensen to the role of Chief Business Officer (CBO) heading Corporate Strategy &...
-
Valby, Danmark, 8. marts 2019 - H. Lundbeck A/S (Lundbeck) annoncerede i dag udnævnelsen af Keld Flintholm Jørgensen til Chief Business Officer (CBO). Keld skal stå i spidsen for Corporate Strategy...
-
Valby, Denmark, 28 February 2019 – Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on: Tuesday 26 March 2019 at 10:00 am The general meeting will...
-
Valby, Danmark, 28. februar 2019 – Der indkaldes herved til ordinær generalforsamling i H. Lundbeck A/S. tirsdag den 26. marts 2019 kl. 10:00 Generalforsamlingen afholdes på...
-
Valby, Denmark, 18 February 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 28,155 as a consequence of the exercise of employee warrants. ...
-
Valby, Danmark, 18. februar 2019 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort beslutningen om at udvide aktiekapitalen med DKK 28.155 som følge af udnyttelsen af medarbejder-warrants. ...
-
The efficacy of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with bipolar I disorder was investigated in two three-week, double-blind,...